Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:JKI

iShares Morningstar Mid-Cap Value ETF (JKI) Price, Holdings, & News

iShares Morningstar Mid-Cap Value ETF logo

About iShares Morningstar Mid-Cap Value ETF (NASDAQ:JKI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$62.25
$190.39
52-Week Range
N/A
Volume
29,284 shs
Average Volume
6,583 shs
Market Capitalization
$158.41 million
Assets Under Management
$348.15 million
Dividend Yield
2.50%
Net Expense Ratio
0.30%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Morningstar Mid-Cap Value ETF Expenses

TypeJKIMid Cap ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.30%0.36%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.30%0.51%0.76%0.73%0.73%
Fee Waiver0.00%-0.73%-0.66%-0.50%-0.63%
Net Expense0.30%0.39%0.63%0.63%0.60%
Receive JKI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Morningstar Mid-Cap Value ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JKI ETF News Headlines

IMCG: Growth ETF Without Mega Caps
New Biotech Backed by Proven Incubator Now Open to Public
A successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal comes from the same team that helped guide ANOTHER rare disease biotech to a $680M acquisition. Now, they've lined up a new candidate: a drug with orphan status and fast-track designation, entering Phase 2 trials.tc pixel
BlackRock Mid-Cap Value Fund Q2 2024 Commentary
BlackRock Mid-Cap Value Institutional
iShares Morningstar Mid-Cap ETF
See More Headlines

JKI ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Morningstar Mid-Cap Value ETF investors own include Golub Capital BDC (GBDC), Mastercard (MA), Ares Capital (ARCC), Digital Turbine (APPS), Aphria (APHA), American Tower (AMT) and AMC Entertainment (AMC).

Fund Details

Issuer
iShares
Fund Name
iShares Morningstar Mid-Cap Value ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:JKI
Inception Date
6/28/2004
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

Fund Focus

Asset Class
Equity
Benchmark
Morningstar Mid Value Index
Category
Size and Style
Focus
Mid Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$348.15 million
Average Daily Volume
$9.54 thousand
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
0.96
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 JKI Holdings

JKI Sector Exposure

JKI Industry Exposure


This page (NASDAQ:JKI) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners